Geode Capital Management LLC Has $1.75 Billion Stock Holdings in Colgate-Palmolive Company $CL

Geode Capital Management LLC increased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 1.4% during the 4th quarter, HoldingsChannel.com reports. The fund owned 22,103,901 shares of the company’s stock after purchasing an additional 304,426 shares during the period. Geode Capital Management LLC’s holdings in Colgate-Palmolive were worth $1,754,657,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Northwestern Mutual Wealth Management Co. boosted its position in Colgate-Palmolive by 8,040.1% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 4,655,987 shares of the company’s stock valued at $380,666,000 after buying an additional 4,598,789 shares in the last quarter. Diamond Hill Capital Management Inc. boosted its position in Colgate-Palmolive by 46.7% in the third quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock valued at $645,719,000 after buying an additional 2,572,796 shares in the last quarter. Amundi boosted its position in Colgate-Palmolive by 41.6% in the third quarter. Amundi now owns 6,294,445 shares of the company’s stock valued at $487,505,000 after buying an additional 1,850,412 shares in the last quarter. Two Sigma Investments LP boosted its position in Colgate-Palmolive by 360.9% in the third quarter. Two Sigma Investments LP now owns 2,126,249 shares of the company’s stock valued at $169,972,000 after buying an additional 1,664,949 shares in the last quarter. Finally, SG Americas Securities LLC boosted its position in Colgate-Palmolive by 3,896.0% in the fourth quarter. SG Americas Securities LLC now owns 1,189,005 shares of the company’s stock valued at $93,955,000 after buying an additional 1,159,250 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $91.69 on Friday. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The firm has a fifty day simple moving average of $86.24 and a 200 day simple moving average of $85.60. The company has a market capitalization of $73.37 billion, a PE ratio of 35.68, a P/E/G ratio of 4.74 and a beta of 0.31. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. During the same period in the previous year, the firm posted $0.91 earnings per share. The business’s revenue was up 8.4% compared to the same quarter last year. On average, sell-side analysts forecast that Colgate-Palmolive Company will post 3.82 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Monday, April 20th were paid a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.3%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend was Monday, April 20th. Colgate-Palmolive’s payout ratio is presently 82.49%.

Analyst Ratings Changes

CL has been the topic of a number of research analyst reports. Piper Sandler cut their target price on shares of Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. Barclays raised their target price on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 5th. The Goldman Sachs Group restated a “buy” rating on shares of Colgate-Palmolive in a research report on Friday, May 1st. Jefferies Financial Group raised their target price on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Finally, Wells Fargo & Company cut their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 8th. Twelve research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.